In December 2022, Atossa closed their previously announced investment in Dynamic Cell Therapies, Inc. (DCT), a privately held, venture capital backed, developer of CAR-T therapies. DCT is in the pre-clinical phase of developing controllable CAR-T cells to address difficult-to-treat cancers. Its platform technology of dynamic control of engineered T-cells is designed to improve the safety, […]
October is Breast Cancer Awareness Month! This international health campaign is now in its fourth decade. Its purpose is to raise awareness of breast cancer and to increase funding to prevent, diagnose, treat and cure breast cancer – a disease that afflicts over 270,000 women every year in the U.S. alone. In support of Breast […]